Optimizing Cancer Treatment: The Synergy of Multimodal Oncology | Chapter 5 | New Visions in Medicine and Medical Science Vol. 9

 

This chapter is an attempt to offer some perspective on how to apply these disparate methodologies so that they may be more effectively integrated, resulting in consistently better clinical responses. The term “integrative oncology” can mean particular things to different audiences. For the purposes of this chapter, it is intended to mean the simultaneous use of multiple anti-cancer strategies that can have a synergistic effect against the tumor, its microenvironment, and its propensity to metastasize. Thereby, having a maximum impact against the cancer with a minimum of side effects for the patient to endure. This chapter provides a quick overview of the five most common evidence-based systematic techniques now in use, as shown in the sources. Although the efficiency of each of these strategies varies, in my experience, when they are combined therapeutically, the results are exponentially better, changing the focus from progression-free survival to the prospect of improved overall survival and long-lasting remission.

 

Author(s) Details:-

 

Jesse A. Stoff
Integrative Medicine of New York, 520 Franklin Ave Suite 230 Garden City, NY-11530, USA.

 

Please see the link here:-  https://doi.org/10.9734/bpi/nvmms/v9/3803G

New Perspectives of Lupeol in Breast Cancer Prevention – A Mini-review| Chapter 7 | Current Progress in Medicine and Medical Research Vol. 3

 Cancer is a accepted illness that spreads throughout the human party's circulatory plan and eliminates human life. The human bulk contains an abundance of containers that grow, separate, and die conventionally. Occasionally the invulnerable system collapses, and a haphazard number of containers grows, developing in cancer. Cancer cells clump separately and form a tumor, an extra mass of fabric. Breast cancer is a complex heterogeneous affliction that has been formal as the world's second-largest root of humanness. Therefore, therapeutic strategies are flattering highly useless is reached clinical shortage due to massive aftereffects and multidrug resistance. Lupeol is non-poisonous, further study is needed to decide its chemo-preventive potential as a better alternative to inevitable chemotherapeutic agents in feelings cancer patients. Therefore, in this place chapter, we fundamentally renew Lupeol’s preventive characteristics in the breast cancer model, accompanying a focus on multi-targeted everyday and molecular impacts.

Author(s) Details:

Susmitha Ravichandran,

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Chidambaram – 608 002, Tamil Nadu, India.

Mirunalini Sankaran,

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Chidambaram – 608 002, Tamil Nadu, India.

Please see the link here: https://stm.bookpi.org/CPMMR-V3/article/view/11240